Mitchell Shirvan Insider Profile
4 Followers
Mitchell Shirvan, VP Innovation & Discovery at Foamix Pharma, holds 27.89K shares in Silexion Therapeutics (Ticker: SLXN), holds 24.98K shares in Foamix Pharma (Ticker: FOMX). Most recently, Mitchell Shirvan Sold ― shares of Silexion Therapeutics on Mar 30, 2026 for an estimated value of $31.03K.
Mitchell Shirvan Foamix Pharma (FOMX)VP Innovation & Discovery
Foamix Pharma (FOMX)
VP Innovation & Discovery
Not Ranked
Mitchell Shirvan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Mitchell Shirvan's holdings
Insider Roles
CSO and CDO
Roles that Mitchell Shirvan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mitchell Shirvan
Mitchell Shirvan's Trading History
Foamix Pharma
Feb 28, 2018
―
Uninformative Buy
―
$74.69K
Silexion Therapeutics
Mar 30, 2026
CSO and CDO
Informative Sell
31.03K
$31.24K
List of latest transactions for each holding click on a transaction to see Mitchell Shirvan's performance on stock
You May Also Like
Mitchell Shirvan insider profile FAQ
What is the percentage of profitable transactions made by Mitchell Shirvan?
The percentage of profitable transactions made by Mitchell Shirvan is ―.
What is the average return per transaction made by Mitchell Shirvan?
The average return per transaction made by Mitchell Shirvan is ―.
What stocks does Mitchell Shirvan hold?
Mitchell Shirvan holds: FOMX, SLXN stocks.
What was Mitchell Shirvan’s latest transaction?
Mitchell Shirvan latest transaction was an Informative Sell of $31.03K.
What was Mitchell Shirvan's most profitable transaction?
Mitchell Shirvan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mitchell Shirvan's role in Foamix Pharma?
Mitchell Shirvan's role in Foamix Pharma is VP Innovation & Discovery.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.